Related Experiment Video
Updated: Jul 20, 2025

09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
17.5K
Alternative Splicing of RIOK3 Engages the Noncanonical NFκB Pathway during Rift Valley Fever Virus Infection.
Thomas Charles Bisom1, Hope Smelser1, Jean-Marc Lanchy2
1Department of Chemistry and Biochemistry, University of Montana, Missoula, MT 59801, USA.
Viruses
|July 29, 2023
Summary
Rift Valley fever virus infection triggers alternative splicing of RIOK3 mRNA, activating the noncanonical NFκB pathway. This viral strategy suppresses the interferon response, enhancing viral success.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The noncanonical NFκB pathway, initially linked to lymphoid organogenesis, is increasingly recognized for its role in innate immunity.
- RNA viruses can activate and exploit the noncanonical NFκB pathway during infection, often to disrupt type 1 interferon (IFN) transcription.
- Rift Valley fever virus (RVFV) is a significant pathogen affecting livestock and human health.
Purpose of the Study:
- To investigate the role of RIOK3 alternative splicing in RVFV infection.
- To determine the association between RIOK3 alternative splicing and the noncanonical NFκB pathway.
- To elucidate how RVFV (MP12 strain) might co-opt cellular pathways for its replication.
Main Methods:
- Analysis of RIOK3 mRNA splicing patterns following RVFV infection.
- Assessment of noncanonical NFκB pathway activation.
- Evaluation of the impact of RIOK3 splicing on IFN response and viral replication.
Main Results:
- RVFV (MP12 strain) infection leads to alternative splicing of RIOK3 mRNA, generating a truncated RIOK3 protein (X2 isoform).
- This alternative splicing inhibits the IFN response while simultaneously activating an NFκB-mediated inflammatory response.
- The alternative splicing of RIOK3 mRNA is directly associated with the activation of the noncanonical NFκB pathway.
Conclusions:
- Alternative splicing of RIOK3 mRNA is a key event during RVFV infection.
- RVFV appears to co-opt the noncanonical NFκB pathway, facilitated by RIOK3 alternative splicing, to suppress host antiviral defenses.
- This mechanism likely contributes to viral success and pathogenesis by modulating both IFN and NFκB signaling.
More Related Videos
Related Concept Videos
Alternative RNA Splicing
3.8K
3.8K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Pre-mRNA Processing: RNA Splicing
5.3K
5.3K

